findmyKOL
Clinical trialNCT04364035CompletedPhase 2Interventional

Safety, Tolerability and Immunogenicity of MVA.HTI and ChAdOx1.HTI With Vesatolimod in HIV-1 Positive Patients

SponsorAelix TherapeuticsEnrollment50HIV/AIDS
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Spain
  • Irsicaixa Aids Research Institute, Hospital Universitari Germans Trias I Pujol

    Badalona, Barcelona, Spain

  • Hospital Universitario de Bellvitge

    L'Hospitalet de Llobregat, Barcelona, Spain

  • Hospital Clinic de Barcelona

    Barcelona, Spain

  • Hospital Universitario Vall D'Hebrón

    Barcelona, Spain

  • Hospital de la Santa Creu I Sant Pau

    Barcelona, Spain

  • Hospital General Universitario Gregorio Marañón

    Madrid, Spain

  • Hospital la Princesa

    Madrid, Spain

  • Hospital Universitario la Paz

    Madrid, Spain

  • Hospital Universitario Ramon Y Cajal

    Madrid, Spain

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
20 Feb 2020
Primary completion
3 Oct 2022
Completion
16 Dec 2022
Last update posted
27 Jul 2023
Registered enrollment
50
Registry id
NCT04364035

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.